Back to Search
Start Over
IL-37 blocks gouty inflammation by shaping macrophages into a non-inflammatory phagocytic phenotype.
- Source :
-
Rheumatology . Sep2022, Vol. 61 Issue 9, p3841-3853. 13p. - Publication Year :
- 2022
-
Abstract
- Objective Interleukin (IL)-37 is a natural suppressor of inflammation. Macrophages play an important role in acute gout flare by dominating the inflammation and spontaneous relief. We have reported that IL-37 could limit runaway inflammation in gout. Here we focus on whether IL-37 inhibits gouty inflammation by altering macrophage functions, and how it does so. Methods Macrophage functions were evaluated in terms of phagocytosis, pyroptosis, polarization and metabolism. Phagocytosis and polarization of macrophages were detected by side scattering and double-labelling induced nitrogen monoxide synthase (iNOS)/arginase-1 (Arg-1) using flow cytometry, respectively. Transcription of pyroptosis-related molecules was detected by qPCR. Metabolomics was performed by liquid chromatograph mass spectrometer. Human IL-37 knock-in mice and a model with point mutation (S9A) at mouse Gsk3b locus were created by CRISPR/Cas-mediated genome engineering. MSU was injected into the paws and peritoneal cavity to model acute gout. Vernier calliper was used to measure the thickness of the paws. The mice paws and human synovium tissues or tophi were collected for pathological staining. Peritoneal fluid of mice was used to enrich macrophages to detect polarization. Results IL-37 promoted non-inflammatory phagocytic activity of macrophages by enhancing phagocytosis of MSU, reducing transcription of pyroptosis-related proteins and release of inflammatory cytokines, protecting mitochondrial function, and mediating metabolic reprogramming in MSU-treated THP-1 cells. These multifaceted roles of IL-37 were partly depended on the mediation of glycogen synthase kinase-3β (GSK-3β). Conclusions Our study revealed that IL-37 could shape macrophages into a 'silent' non-inflammatory phagocytic fashion. IL-37 may become a potentially valuable treatment option for patients of chronic gout, especially for those with tophi. [ABSTRACT FROM AUTHOR]
- Subjects :
- *INFLAMMATION prevention
*INTERLEUKINS
*FLOW cytometry
*CYTOKINES
*GENETIC mutation
*PHAGOCYTOSIS
*METABOLOMICS
*LIQUID chromatography
*ANIMAL experimentation
*MACROPHAGES
*PHAGOCYTES
*APOPTOSIS
*MITOCHONDRIA
*ANISOTROPY
*MASS spectrometry
*GENOMES
*GENETIC engineering
*TRANSFERASES
*FLUORIMETRY
*INFLAMMATORY mediators
*TRANSCRIPTION factors
*GOUT
*PHENOTYPES
*MICE
Subjects
Details
- Language :
- English
- ISSN :
- 14620324
- Volume :
- 61
- Issue :
- 9
- Database :
- Academic Search Index
- Journal :
- Rheumatology
- Publication Type :
- Academic Journal
- Accession number :
- 158846386
- Full Text :
- https://doi.org/10.1093/rheumatology/keac009